Literature DB >> 29656317

Inflammatory Response of Pulmonary Artery Smooth Muscle Cells Exposed to Oxidative and Biophysical Stress.

Joanna Costa1,2,3, Yan Zhu1,2, Timothy Cox4, Paul Fawcett5, Thomas Shaffer1,2,3,6, Deepthi Alapati7,8,9,10.   

Abstract

Pulmonary hypertension in the neonate requires treatment with oxygen and positive pressure ventilation, both known to induce lung injury. The direct response of pulmonary artery smooth muscle cells, the most abundant cells in the artery wall, to the stress of positive pressure and hyperoxia has not been previously studied. Pulmonary artery smooth muscle cells were cultured in temperature- and pressure-controlled air-tight chambers under conditions of positive pressure or hyperoxia for 24 h. Control cells were cultured in room air under atmospheric pressure. After the exposure period, culture medium was collected and samples were analyzed by ELISA, Human Cytokine 25-Plex Panel using a Luminex 200 analyzer and Western blot. Secretion of various inflammatory mediators, specifically IL-6, IL-8, IL-2R, MIP-1β, MCP-1, IP-10, IL-7, IL-1RA, and IFN-α, was higher in the positive pressure and hyperoxia groups compared with control. The level of cyclin D1 was decreased in the hyperoxia and positive pressure group compared with control. Levels of fibronectin and α-smooth muscle actin were not different among the groups. Pulmonary artery smooth muscle cells directly produce multiple inflammatory mediators in response to oxidative and biophysical stress in vitro, which may be part of a cascade that leads to the vascular and perivascular changes in pulmonary hypertension.

Entities:  

Keywords:  hyperoxia; inflammation; positive pressure; pulmonary hypertension

Mesh:

Substances:

Year:  2018        PMID: 29656317     DOI: 10.1007/s10753-018-0772-0

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  43 in total

1.  Prospective analysis of pulmonary hypertension in extremely low birth weight infants.

Authors:  Ramachandra Bhat; Ariel A Salas; Chris Foster; Waldemar A Carlo; Namasivayam Ambalavanan
Journal:  Pediatrics       Date:  2012-02-06       Impact factor: 7.124

Review 2.  Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension.

Authors:  Marc Humbert; David Montani; Frédéric Perros; Peter Dorfmüller; Serge Adnot; Saadia Eddahibi
Journal:  Vascul Pharmacol       Date:  2008-06-20       Impact factor: 5.773

Review 3.  Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms.

Authors:  Kurt R Stenmark; Karen A Fagan; Maria G Frid
Journal:  Circ Res       Date:  2006-09-29       Impact factor: 17.367

4.  High tidal volume ventilation activates Smad2 and upregulates expression of connective tissue growth factor in newborn rat lung.

Authors:  Shu Wu; Letizia Capasso; Andrea Lessa; Jinghong Peng; Kalyani Kasisomayajula; Maria Rodriguez; Cleide Suguihara; Eduardo Bancalari
Journal:  Pediatr Res       Date:  2008-03       Impact factor: 3.756

5.  Decreased numbers of T-lymphocytes and predominance of recently recruited macrophages in the walls of peripheral pulmonary arteries from 26 patients with pulmonary hypertension secondary to congenital cardiac shunts.

Authors:  Rubens Fraga Alves Pinto; Maria de Lourdes Higuchi; Vera Demarchi Aiello
Journal:  Cardiovasc Pathol       Date:  2004 Sep-Oct       Impact factor: 2.185

6.  Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis.

Authors:  Ignatios Ikonomidis; John P Lekakis; Maria Nikolaou; Ioannis Paraskevaidis; Ioanna Andreadou; Theophania Kaplanoglou; Pelagia Katsimbri; Grigorios Skarantavos; Panayiotis N Soucacos; Dimitrios T Kremastinos
Journal:  Circulation       Date:  2008-05-12       Impact factor: 29.690

7.  Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.

Authors:  N F Voelkel; R M Tuder; J Bridges; W P Arend
Journal:  Am J Respir Cell Mol Biol       Date:  1994-12       Impact factor: 6.914

Review 8.  Cellular interplay in pulmonary arterial hypertension: implications for new therapies.

Authors:  Rita Nogueira-Ferreira; Rita Ferreira; Tiago Henriques-Coelho
Journal:  Biochim Biophys Acta       Date:  2014-01-31

9.  Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension.

Authors:  R P Mecham; L A Whitehouse; D S Wrenn; W C Parks; G L Griffin; R M Senior; E C Crouch; K R Stenmark; N F Voelkel
Journal:  Science       Date:  1987-07-24       Impact factor: 47.728

10.  Pulmonary vascular dysfunction induced by high tidal volume mechanical ventilation.

Authors:  Carmen Menendez; Leticia Martinez-Caro; Laura Moreno; Nicolas Nin; Javier Moral-Sanz; Daniel Morales; Angel Cogolludo; Andres Esteban; Jose A Lorente; Francisco Perez-Vizcaino
Journal:  Crit Care Med       Date:  2013-08       Impact factor: 7.598

View more
  2 in total

1.  Prenatal treatment with rosiglitazone attenuates vascular remodeling and pulmonary monocyte influx in experimental congenital diaphragmatic hernia.

Authors:  Jan-Hendrik Gosemann; Florian Friedmacher; Alejandro Hofmann; Julia Zimmer; Joachim F Kuebler; Susanne Rittinghausen; Anne Suttkus; Martin Lacher; Luis Alvarez; Nicolae Corcionivoschi; Prem Puri
Journal:  PLoS One       Date:  2018-11-12       Impact factor: 3.240

2.  Association of plasma adiponectin with pulmonary hypertension, mortality and heart failure in African Americans: Jackson Heart Study.

Authors:  Suvasini Lakshmanan; Matthew Jankowich; Wen-Chih Wu; Siddique Abbasi; Alan R Morrison; Gaurav Choudhary
Journal:  Pulm Circ       Date:  2020-11-11       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.